163 related articles for article (PubMed ID: 18573693)
21. National French observatory of the quality of blood components for transfusion.
Chabanel A; Masse M; Begue S;
Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
[TBL] [Abstract][Full Text] [Related]
22. Leukocyte-poor blood.
Wenz B
Crit Rev Clin Lab Sci; 1986; 24(1):1-20. PubMed ID: 3539518
[TBL] [Abstract][Full Text] [Related]
23. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.
Eder AF; Dy BA; Kennedy JM; Notari Iv EP; Strupp A; Wissel ME; Reddy R; Gibble J; Haimowitz MD; Newman BH; Chambers LA; Hillyer CD; Benjamin RJ
Transfusion; 2008 Sep; 48(9):1809-19. PubMed ID: 18631167
[TBL] [Abstract][Full Text] [Related]
24. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
[TBL] [Abstract][Full Text] [Related]
25. [Labile blood products and their preparation].
Chabanel A; Folléa G
Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
[TBL] [Abstract][Full Text] [Related]
26. [Blood components: indication and notice of transfusion].
Sekiguchi S
Nihon Rinsho; 1997 Sep; 55(9):2205-13. PubMed ID: 9301278
[TBL] [Abstract][Full Text] [Related]
27. Quality and standardization in blood component preparation with an automated blood processing technique.
van Rhenen DJ; Vermeij J; de Voogt J; Bernes JC; Payrat JM
Transfus Med; 1998 Dec; 8(4):319-24. PubMed ID: 9881426
[TBL] [Abstract][Full Text] [Related]
28. Blood component collection by apheresis.
Burgstaler EA
J Clin Apher; 2006 Jul; 21(2):142-51. PubMed ID: 15880369
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the quality of blood components prepared using the Reveos automated blood processing system.
Johnson L; Winter KM; Kwok M; Reid S; Marks DC
Vox Sang; 2013 Oct; 105(3):225-35. PubMed ID: 23713603
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a conventional quadruple-bag system with a 'top-and-bottom' system for blood processing.
Pietersz RN; Dekker WJ; Reesink HW
Vox Sang; 1990; 59(4):205-8. PubMed ID: 2293459
[TBL] [Abstract][Full Text] [Related]
31. Quality control of buffy coat removed red cell concentrates--a Croatian experience.
Vuk T; Očić T; Patko MS; Jukić I
Transfus Med; 2014 Dec; 24(6):385-91. PubMed ID: 25469715
[TBL] [Abstract][Full Text] [Related]
32. Blood components produced from whole blood using the Atreus processing system.
Thomas S; Beard M; Garwood M; Callaert M; Waeg Gv; Cardigan R
Transfusion; 2008 Dec; 48(12):2515-24. PubMed ID: 18774965
[TBL] [Abstract][Full Text] [Related]
33. [Quality control of platelet concentrates: experience of Sousse (Tunisia) blood centre].
Bouslama M; Abdelkefi S; Houissa B; Zaier M; Hmida H; Ghachem L; Yacoub S
Ann Biol Clin (Paris); 2004; 62(1):115-9. PubMed ID: 15047502
[TBL] [Abstract][Full Text] [Related]
34. Platelet activation during storage of platelet concentrates processed from buffy coats by the automated OrbiSac system.
Larrea González L; Oritiz de Salazar MI; Roig R; Soler MA
Transfusion; 2007 Aug; 47(8):1555-6; author reply 1556. PubMed ID: 17655605
[No Abstract] [Full Text] [Related]
35. Improved BC method of Compomat G4 for expression of BCs twice from whole blood in top and top bags.
Deng XY; Wu XM; Zhao Y; Luo H; Jia HY; Wang ZY; He B; Wang CX
Int J Hematol; 2011 May; 93(5):660-663. PubMed ID: 21516305
[TBL] [Abstract][Full Text] [Related]
36. Segments from red blood cell units should not be used for quality testing.
Kurach JD; Hansen AL; Turner TR; Jenkins C; Acker JP
Transfusion; 2014 Feb; 54(2):451-5. PubMed ID: 23834158
[TBL] [Abstract][Full Text] [Related]
37. National evaluation of IMAGN 2000 for quality monitoring of leucodepleted red cell and platelet concentrates: comparison with flow and Nageotte.
Seghatchian J; Krailadsiri P; Chandegra B; Beard M; Beckman N; Bissett L; Morris B; Booker W
Transfus Sci; 2000; 22(1-2):77-9. PubMed ID: 10771390
[No Abstract] [Full Text] [Related]
38. Use of statistical process control in the production of blood components.
Magnussen K; Quere S; Winkel P
Transfus Med; 2008 Jun; 18(3):190-6. PubMed ID: 18598282
[TBL] [Abstract][Full Text] [Related]
39. Prediction of the effect of acute normovolemic hemodilution on the hematological constituents of sequestered autologous whole blood.
Loubser PG; Chan A
Anesth Analg; 2006 Apr; 102(4):991-7. PubMed ID: 16551887
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and biocompatibility of three different leukocyte and fat removal filters during cardiac surgery.
de Vries AJ; Vermeijden WJ; Gu YJ; Hagenaars JA; van Oeveren W
Artif Organs; 2006 Jun; 30(6):452-7. PubMed ID: 16734597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
